通力律师事务所 is a law firm providing legal services in various fields. self-described.

通力律师事务所

Llinks Law Offices | 1,889 followers on LinkedIn. We link local intelligence with the world. | Llinks Law Offices is a leading PRC law firm with a nationwide and international practice. With offices in Shanghai, Beijing, Shenzhen, Hong Kong and London, we aim to help our clients achieve their business goals and provide professional services of the highest calibre, combining technical excellence with commercial awareness and a practical, constructive approach to legal issues. 

Since its founding in 1998, Llinks has consistently been at the forefront of developments in China’s legal service market.

Charles Qin

Partner at LLinks Law Offices

Selena She

Partner at Llinks Law Offices

Feihong (Nicholas) Lou

lawyer at llinks law firm

Wang Leo(王利民)

Llinks Law Offices

🌟 Llinks Law Offices proudly supported Centurium Capital in its recent A+ investment in Shenzhen Hansitong Automotive Electronics Co., Ltd. (“Hansitong”), a leading innovator in automotive intelligence solutions. Founded in 2013, Hansitong specializes in advanced R&D and manufacturing of intelligent vehicle products, including Cockpit Domain Controllers (CDC), Windshield and AR Head-Up Displays (HUD), multimedia information systems, and more. With extensive expertise in full-stack R&D across optics, electronics, software, and algorithms, Hansitong has established itself as an industry leader. This year, Hansitong’s groundbreaking LCoS AR-HUD solution reached automotive-grade mass production, and it’s now being supplied to major car manufacturers globally. Backed by Centurium Capital—Geely’s strategic investment arm focusing on electric vehicles, smart driving, and intelligent manufacturing—Hansitong will leverage this latest funding round to expand R&D, boost production capacity, and accelerate market delivery. #LlinksLaw #Investment #AutomotiveInnovation #IntelligentVehicles #ARHUD #VentureCapital #Geely

🌟 Exciting News! Shanghai Hile Bio-Technology Co., Ltd. (Hile Bio, stock code: 603718) successfully completed the transfer of assets for its significant purchase and sale transactions. This dual-transaction involves two independent parts: 1️⃣ Acquisition of a 55% stake in Shaanxi Ruisheng Biotechnology Co., Ltd. from Maylion Management Limited for RMB 935 million. 2️⃣ Sale of a 30% stake in WuXi Vaccines (Cayman) Inc. to WuXi Biologics for USD 108.5 million. With these moves, Hile Bio welcomes Ruisheng Biotechnology, a leader in oral tissue regeneration, as a new majority-owned subsidiary, strengthening Hile Bio's market position and long-term growth capacity. 📈 As legal advisors to Hile Bio, Llinks provided comprehensive legal services throughout the project, covering due diligence, commercial negotiations, agreement drafting, and regulatory review. #HileBio #LlinksLawOffices #MergersAndAcquisitions #LifeSciences #LegalAdvisory #Biotechnology

🎉 Llinks Honored with Six Top Awards at the 2024 IFLR1000 China Awards! 🎉 We are thrilled to announce that Llinks Law Offices has been recognized with six prestigious awards at the 2024 IFLR1000 China Awards! 🏆 These awards celebrate the most innovative transactions and top-performing law firms and lawyers across China, showcasing the exceptional expertise and dedication of our team. 🎀 Regional Impact Deals 🎀 Shanghai Capital Markets 🥉 Hua Hong Semiconductor SSE STAR IPO Restructuring and Insolvency 🥉 Flower King International Engineering Group Restructuring This recognition reflects Llinks' continued commitment to providing top-tier legal services in financial and corporate law. 🌍✨ We are proud to have earned a well-deserved reputation within the legal community. A big thank you to everyone who made this achievement possible! 🙌 We look forward to continuing our journey of excellence in legal services. 🔑 #LlinksLaw #IFLR1000 #LegalAwards #FinancialLaw #CorporateLaw #Innovation #LegalExcellence

🎉 Llinks Receives Multiple Nominations at the 2024 IFLR1000 China Awards! 🎉 We are excited to announce that Llinks Law Offices and our talented lawyers have been shortlisted for several prestigious awards in the 2024 IFLR1000 China Awards, recognizing our excellence across a variety of practice areas. 🏆 The IFLR1000 China Awards celebrate the most innovative deals and top-performing firms and lawyers in China over the past year. We are deeply honored by these nominations and grateful to our clients and team for their trust and dedication. 🙌 Stay tuned for the winners' announcement on September 27, 2024! 📅 🔑 #LlinksLaw #IFLR1000 #LegalAwards #CapitalMarkets #MandA #Restructuring #BankingAndFinance #LegalInnovation

🌟 Llinks Recognized by asialaw in 2024 Rankings! 🌟 We are thrilled to announce that Llinks Law Offices has been named a leading law firm in 11 practice areas and 9 industry sectors in the newly released 2024 asialaw Profiles! 🏆 In addition to this firm-wide recognition, 8 of our partners have been honored across 6 practice areas and 2 industry sectors in the asialaw Leading Lawyers rankings. This acknowledgment is a testament to our commitment to delivering exceptional legal services and the trust we have earned in the market. Thank you to our clients and partners for your continued support, and congratulations to our talented team! 🎉 🔑 #LlinksLaw #LegalExcellence #Asialaw #LeadingLawFirm #LegalServices #BusinessLaw #IndustryLeaders #TopLawyers

🌕 Happy Mid-Autumn Festival from LLinks Law Offices! 🏮 As we celebrate the Mid-Autumn Festival, a time for reunion and harmony, we wish all our clients, colleagues, and friends happiness, prosperity, and success. 🎑 Just as the full moon 🌕 symbolizes unity and completeness, we hope this festival brings joy and togetherness to you and your loved ones. 🥮👨👩👧👦 May this festive season illuminate your path with success and bring cherished moments to share with family and friends. ✨ #MidAutumnFestival #MoonFestival #Celebration #LLinksLawOffices

🚀 Llinks Advises Ventech China on Investment in Voyage Foods! 🚀 We are proud to announce that Llinks Law Offices has provided legal counsel to Ventech China in their recent multi-million dollar investment in the U.S. food tech innovator, Voyage Foods . This latest funding round brings Voyage Foods’ total funding close to $100 million! 💼 Founded in 2021, Voyage Foods is transforming the food industry with sustainable alternatives to traditional products like peanut butter, chocolate, and coffee. Their peanut-free peanut butter and hazelnut-free spread are already on the shelves of over 1,200 Walmart stores in the U.S., and their groundbreaking bean-free coffee is 40% cheaper than conventional coffee! ☕🌱 Voyage Foods is rapidly expanding its partnerships, including an exclusive global B2B distribution deal with Cargill 嘉吉公司 , and is set to enter the Asian market with support from Ventech China. We’re honored to assist Ventech China in making this strategic investment and supporting the growth of environmentally friendly and innovative food solutions. 🔑 #FoodTech #SustainableFood #VentureCapital #VoyageFoods #LlinksLaw #VentechChina #Innovation #Investment #AllergenFriendly #AsiaExpansion

🚀 Successful H Share Full Circulation for Wise Living! 🚀 We are proud to have Llinks Law Offices (Hong Kong and Shanghai) advise Wise Living Technology Co., Ltd. ( 02481.HK ) on the successful conversion of 226 million unlisted shares into H shares, now listed on the Main Board of the Hong Kong Stock Exchange. 🎉 Our Hong Kong and Shanghai teams (Head partner: Dennis Fong ) provided comprehensive legal services, guiding Wise Living through the regulatory processes in both jurisdictions. From drafting key documents to liaising with regulatory authorities, this marks another milestone following our role in Wise Living's initial listing in 2023. Wise Living, a leading heat service provider in China’s “Three North Region,” continues to expand, and we’re proud to have supported their H share full circulation. https://lnkd.in/ek-vqHYA 🔑 #CorporateLaw #CapitalMarkets #HShareListing #WiseLiving #LlinksLaw #HongKongLaw #PRCLaw #Securities #LegalServices #CrossBorderTransactions

🚀 A big shout to Llinks Team Advice on Strategic Biopharma Collaboration, Strengthening Shanghai Allist Pharmaceuticals Co., Ltd ’s Oncology Pipeline 🚀 Shanghai Allist Pharmaceuticals Co., Ltd ( 688578.SH ) has signed a strategic collaboration with Jacobio Pharma ( 1167.HK ), securing exclusive rights in Greater China for the KRAS G12C inhibitor Goralresib and SHP2 inhibitor JAB-3312. This partnership strengthens Allist's cancer treatment pipeline, with Goralresib already under priority review and JAB-3312 in Phase III trials. 💼 This partnership not only strengthens Allist’s oncology pipeline, targeting lung, pancreatic, and colorectal cancers, but also positions us to bring innovative treatments to patients in need. Notably, Goralresib's New Drug Application for second-line NSCLC with KRAS G12C mutation has received priority review as of May 21, 2024. Meanwhile, JAB-3312, as the first SHP2 inhibitor to enter a pivotal clinical trial, is set to offer a new treatment option with its unique “dual oral therapy” approach. 🎯 In this significant transaction, Llinks legal team(Head partner Xun Yang ) provided comprehensive legal services to Allist Pharmaceuticals. From strategizing and drafting the licensing agreement to negotiations and advising on critical issues such as international multicenter cooperation and clinical development handover, Llinks' expertise has once again been integral in driving forward Allist's business development (BD) initiatives. 🔑 #AllistPharma #JACOBIOPharma #OncologyInnovation #LegalServices #TechLaw #Biopharma #StrategicPartnership #ClinicalTrials #KRASG12C #SHP2Inhibitor #Oncology #Biopharma #LegalServices #StrategicPartnership #ClinicalTrials #Innovation

🌟 Great News! 🌟 I'm thrilled to share that today, the IFLR1000 China Rankings 2024/25 have been released by the IFLR International Financial Law Review . Five talented partners(@Christophe Han, David Yu , @Grant Chen, Selena She , Yuan Huang) from our firm have been recognized for their outstanding professional performance and solid expertise across five specialized areas in the Chinese legal services market. 🌟👏 Recognized areas: 📍 Shanghai 🏅 Banking and Finance 🏅 Capital Markets 🏅 Mergers & Acquisitions 🏅 Private Equity 🏅 Investment Funds Congratulations to our amazing team! 🎉 #LegalExcellence #IFLR1000 #LawFirm #Shanghai #BankingFinance #CapitalMarkets #MandA #PrivateEquity #InvestmentFunds #LegalServices

Metric
Company Name	通力律师事务所
Symbol
MSH ID	COM:LLINKSLAW
Market	PRIVATE
Sector	Commercial & Professional Services
Industry	Legal Services
Country	CN
Stage
Employee Count
Website	llinkslaw.com
LinkedIn	llinks-law-offices
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	17.84K
Web Traffic Growth	-0.38
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

LLIN

COM:LLINKSLAW

通力律师事务所

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue